BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, June 16, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 3, 2018
View Archived Issues
Nudt15-knockout mouse model shown useful to guide thiopurine dosing in ALL
Read More
Atara Biotherapeutics announces initiation of phase III clinical program for tabelecleucel
Read More
First patient dosed in phase III trial of tislelizumab in HCC
Read More
Cascadian Therapeutics receives pediatric investigation plan waiver from EMA for tucatinib
Read More
NexImmune closes series A financing to support initiation of phase I/II trial of AIM ACT
Read More
IQGAP1 identified as a potential therapeutic target for AML treatment
Read More
Protalix BioTherapeutics reports interim data from phase II study of OPRX-106
Read More
FDA grants priority review to Achaogen's plazomicin NDA
Read More
Centrexion Therapeutic raises funds for phase III development of CNTX-4975
Read More
Five Prime initiates phase I portion of FIGHT trial of FPA-144 in advanced gastric cancer
Read More
FDA grants breakthrough therapy designation to Kisqali for premenopausal breast cancer
Read More
Achaogen reports topline results from first clinical trial of C-Scape
Read More
Tetraphase submits NDA for intravenous eravacycline to treat cIAI
Read More
FDA accepts Olinvo NDA
Read More
New anti-BCMA-CAR therapy for MM shows promise in preclinical phase
Read More
Addex and Indivior sign licensing and collaboration agreement for ADX-71441 to treat addiction
Read More
SciFluor Life Sciences patents novel KCNQ2/3 activators
Read More
Chinese researchers disclose kappa-opioid receptor agonists
Read More
Enanta Pharmaceuticals identifies anti-HBV compounds
Read More
Bayer presents novel IRAK-4 inhibitors
Read More
New TBK1 and IKK-E inhibitors presented by Bayer
Read More
Researchers present novel BALB/c mouse model of PRV infection
Read More
Galapagos updates status of cystic fibrosis pipeline
Read More
